Auxly Research And Ddevelopement To Revenue from 2010 to 2025

XLY Stock  CAD 0.07  0.01  6.67%   
Auxly Cannabis Research And Ddevelopement To Revenue yearly trend continues to be very stable with very little volatility. Research And Ddevelopement To Revenue is likely to drop to 0. Research And Ddevelopement To Revenue is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. View All Fundamentals
 
Research And Ddevelopement To Revenue  
First Reported
2010-12-31
Previous Quarter
0.003554
Current Value
0.003377
Quarterly Volatility
3.16306709
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Auxly Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Auxly Cannabis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.5 M, Interest Expense of 31.1 M or Total Revenue of 122.1 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.17. Auxly financial statements analysis is a perfect complement when working with Auxly Cannabis Valuation or Volatility modules.
  
This module can also supplement various Auxly Cannabis Technical models . Check out the analysis of Auxly Cannabis Correlation against competitors.

Other Information on Investing in Auxly Stock

Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.